Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Clinical Trials in South Carolina

134 recruiting clinical trials across 15 cities in South Carolina (SC). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
134
Total Trials
134
Recruiting Now
15
Cities
20
Conditions

Recruiting Trials in South Carolina

Clinical trial data sourced from ClinicalTrials.gov. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT00756769

Systemic Lupus Erythematosus in Gullah Health

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the production of autoantibodies, multiple organ involvement, and diverse clinical symptoms and...

Sponsor: Medical University of South CarolinaEnrolling: 7501 location
Systemic Lupus Erythematosus
RECRUITINGNCT02432560

Safety and Durability of Sirolimus for Treatment of LAM

The MIDAS study aims to follow male and female LAM patients who are currently taking, have previously failed or been intolerant of, or may (at some time in the future) take mTOR...

Sponsor: University of CincinnatiEnrolling: 60020 locations
Lymphangioleiomyomatosis
RECRUITINGNCT02855554

Quantitative Cardiac Parametric Mapping

The overall goal of this project is to evaluate the clinical potential of fast quantitative myocardial tissue characterization using recently emerged Cardiac Magnetic Resonance...

Sponsor: Medical University of South CarolinaEnrolling: 2401 location
Cardiomyopathy, Myocarditis, Ischemic Heart Disease
RECRUITINGNCT03941379

A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma

The purpose of this observational research study is to follow participants who have been treated with either bel-sar or received alternate treatment (sham, standard of care...

Sponsor: Aura BiosciencesEnrolling: 50016 locations
Choroidal MelanomaIndeterminate Lesions of Eye
RECRUITINGPhase 4NCT03987763

A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis

This study is to evaluate the safety, the systemic exposure of halobetasol propionate (HP), and the hypothalamic-pituitary-adrenal (HPA) axis suppression potential for topically...

Sponsor: Bausch Health Americas, Inc.Enrolling: 459 locations
Psoriasis
RECRUITINGPhase 1NCT04294043

IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)

The purpose of this study is to assess the safety and tolerability of two 5-day infusion cycles of IV gallium in adult patients with CF who are infected with NTM. Funding Source...

Sponsor: Chris GossEnrolling: 4010 locations
Nontuberculous Mycobacterium Infection
RECRUITINGNCT04469439

Impact of Sinus Surgery on Individuals With Cystic Fibrosis

This study will be a prospective, observational study of patients who undergo endoscopic sinus surgery for cystic fibrosis-related chronic rhinosinusitis (CRS). Individuals who do...

Sponsor: University of California, Los AngelesEnrolling: 1709 locations
Chronic Rhinosinusitis (Diagnosis)Cystic Fibrosis
RECRUITINGEarly Phase 1NCT04541108

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

This is a multi-center, open-label Phase 0 Master Protocol designed to study the localized pharmacodynamics (PD) of anti-cancer therapies within the tumor microenvironment (TME)...

Sponsor: Presage BiosciencesEnrolling: 1512 locations
Solid Tumor
RECRUITINGNCT04564989

Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC

The primary goal of this study is to examine whether recurrence of HPV-associated OPSCC can be predicted by two factors: 1) mutations in genes called TRAF3 and CYLD, and 2)...

Sponsor: UNC Lineberger Comprehensive Cancer CenterEnrolling: 2203 locations
Oropharyngeal Squamous Cell CarcinomaCarcinoma, Squamous CellHead and Neck Squamous Cell Carcinoma+1
RECRUITINGNCT04592445

Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF

The purpose of this clinical study is to evaluate the safety and early effectiveness of a catheter-based procedure that treats a nerve called the right greater splanchnic nerve....

Sponsor: Axon Therapies, INC.Enrolling: 15020 locations
Heart Failure With Preserved Ejection Fraction (HFpEF
RECRUITINGPhase 3NCT04620239

ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study

This is a phase 3, open label, single arm study of padeliporfin in the treatment of Upper Tract Urothelial Carcinoma (UTUC). The ENLIGHTED study will recruit patients with...

Sponsor: Steba Biotech S.A.Enrolling: 10018 locations
Transitional Cell Cancer of Renal Pelvis and Ureter
RECRUITINGPhase 3NCT04877197

Behavioral Activation Delivered Via Home-based Telehealth to Improve Functioning in Cardiovascular Disease Patients...

The purpose of this study is to demonstrate whether Behavioral Activation for depression delivered via home based telehealth (BA-HT) is effective in improving social and role...

Sponsor: Va Office of Research and DevelopmentEnrolling: 1321 location
DepressionCardiovascular Diseases
RECRUITINGPhase 1 / Phase 2NCT04938817

Safety and Efficacy Study of Investigational Agents as Monotherapy or in Combination With Pembrolizumab (MK-3475) for...

This study is a rolling arm study of investigational agents as monotherapy or in combination with pembrolizumab in participants with anti-programmed cell death 1 (PD-1)/...

Sponsor: Merck Sharp & Dohme LLCEnrolling: 11020 locations
Small Cell Lung Carcinoma
RECRUITINGPhase 1NCT04970901

A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer...

The primary objective of this study is to characterize the safety and tolerability of loncastuximab tesirine in combination with polatuzumab vedotin, glofitamab, or mosunetuzumab,...

Sponsor: Adc Therapeutics S.a.Enrolling: 20020 locations
B-Cell Non-Hodgkin LymphomaRelapsed B-Cell Non-Hodgkin LymphomaRefractory B-Cell Non-Hodgkin Lymphoma
RECRUITINGPhase 3NCT05024773

Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)

This is a phase III, single-arm, multicenter, international study to assess the efficacy and safety of ONCOFID-P-B following intravesical instillation in adult patients with...

Sponsor: Fidia Farmaceutici s.p.a.Enrolling: 11220 locations
Bladder Carcinoma in Situ (CIS)
RECRUITINGPhase 4NCT05034432

The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients

To investigate the effect of VTA ablation at the time of LVAD implant to see if it can reduce the incidence of VTA after surgery

Sponsor: University of RochesterEnrolling: 10019 locations
ArrythmiaCardiomyopathies
RECRUITINGPhase 2NCT05064319

Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders

This research study evaluates the effects of an FDA-approved medication Gabapentin in individuals with Bipolar Disorder who smoke marijuana. Participants in the study will will be...

Sponsor: Medical University of South CarolinaEnrolling: 681 location
Bipolar DisorderCannabis UseSchizoaffective Disorder, Bipolar Type+5
RECRUITINGNCT05080998

Longitudinal Bladder Cancer Study for Tumour Recurrence

Surveillance for recurrence of urothelial carcinoma (UC) requires frequent cystoscopy, which is invasive, expensive and time-consuming. An accurate urinary biomarker has the...

Sponsor: Pacific Edge LimitedEnrolling: 4507 locations
Urothelial Bladder Cancer
RECRUITINGPhase 4NCT05191706

Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract

A Phase 3/4, Prospective, Randomized, Active Treatment-Controlled, Parallel-Design, Multicenter Study to Evaluate the Safety of DEXYCUfor the Treatment of Inflammation Following...

Sponsor: EyePoint Pharmaceuticals, Inc.Enrolling: 609 locations
Cataract
RECRUITINGPhase 1 / Phase 2NCT05197270

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

Phase 1/2 dose-escalation and randomized, controlled, masked expansion trial in adults with wet AMD undergoing active anti-VEGF treatment. Substudies will evaluate the safety and...

Sponsor: 4D Molecular TherapeuticsEnrolling: 21520 locations
Neovascular (Wet) Age-Related Macular Degeneration
RECRUITINGNCT05366881

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

This is an observational case-control study to train and validate a genome-wide methylome enrichment platform to detect multiple cancer types and to differentiate amongst cancer...

Sponsor: Adela, IncEnrolling: 700017 locations
Brain CancerBreast CancerBladder Cancer+17
RECRUITINGPhase 4NCT05390892

PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

PRECIDENTD is a randomized, open label, pragmatic clinical trial designed to compare rates of the total number of cardiovascular, kidney, and death events among two alternative...

Sponsor: Brigham and Women's HospitalEnrolling: 60008 locations
Type2DiabetesASCVD
RECRUITINGNCT05486234

CARS: Cannabis and Alcohol Reduction Study

The study will test a computerized treatment with subjects ages 13-17 years who are seeking treatment for alcohol and/or cannabis use. Follow-up assessments will be conducted at...

Sponsor: Medical University of South CarolinaEnrolling: 521 location
Cannabis UseAlcohol Use, UnspecifiedSubstance Use+1
RECRUITINGNCT05579392

A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis

Crohn's Disease (CD) and Ulcerative Colitis (UC), collectively known as inflammatory bowel disease (IBD), are two of the most significant chronic conditions of the...

Sponsor: Rush University Medical CenterEnrolling: 302 locations
Inflammatory Bowel Disease
RECRUITINGNCT05603728

Exactech Shoulder Post Market Clinical Follow-up Study

The objective of this study is to collect and evaluate long-term clinical and radiographic outcomes data in order to better understand the safety and performance of the shoulder...

Sponsor: ExactechEnrolling: 2000020 locations
Osteo Arthritis ShouldersOsteonecrosisRotator Cuff Tears+6
RECRUITINGPhase 3NCT05645107

A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to...

The primary purpose of the study is to evaluate whether biweekly administered XEMBIFY® plus Standard Medical Treatment (SMT) over a one-year period will reduce the rate of major...

Sponsor: Grifols Therapeutics LLCEnrolling: 38620 locations
HypogammaglobulinemiaBacterial InfectionsB-cell Chronic Lymphocytic Leukemia+2
RECRUITINGPhase 1 / Phase 2NCT05668741

A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF)

The purpose of this study is to evaluate the safety, and tolerability and efficacy of VX-522 in participants 18 years of age and older with cystic fibrosis and a cystic fibrosis...

Sponsor: Vertex Pharmaceuticals IncorporatedEnrolling: 3920 locations
Cystic Fibrosis
RECRUITINGPhase 1 / Phase 2NCT05702853

Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLL

This is a single-center, nonrandomized, open-label dose-escalation study followed by dose-expansion of CD19- CD34t metabolically programmed CAR T-cell therapy in adult patients...

Sponsor: Medical University of South CarolinaEnrolling: 271 location
B-cell Non Hodgkin LymphomaChronic Lymphocytic Leukemia
RECRUITINGNCT05718102

Pragmatic Trial to Enhance Quality Safety, and Patient Experience in COPD

Background: Over 26 million Americans have chronic obstructive pulmonary disease (COPD), which is the third leading cause of death in the United States. Unfortunately, few...

Sponsor: Seattle Institute for Biomedical and Clinical ResearchEnrolling: 40005 locations
Pulmonary Disease, Chronic Obstructive
RECRUITINGPhase 2NCT05730283

Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin

The goal of this clinical trial is to test the effectiveness of the study drug, ORC-13361, in preventing hearing loss in patients with NTM infection who are undergoing treatment...

Sponsor: Kevin WinthropEnrolling: 1055 locations
Ototoxicity, Drug-Induced

Showing 30 of 134 trials in South Carolina. Search all trials

Browse Trials by State

Frequently Asked Questions

There are currently 134 clinical trials actively recruiting participants in South Carolina. These span all phases from early-stage Phase 1 to late-stage Phase 3 trials, across 20+ conditions.

The top conditions with recruiting trials in South Carolina include Substance Use Disorders, Sickle Cell Disease, Opioid Use Disorder, Cystic Fibrosis, Depression. Each has multiple active trials across research centers in the state.

Major trial sites in South Carolina include Charleston, Greenville, Myrtle Beach, Spartanburg, North Charleston. Most large academic medical centers and research hospitals serve as trial sites.

Review the trial listings on this page and check the eligibility criteria — we translate them into plain English. When you find a trial that fits, talk to your doctor about whether it's right for you, then contact the trial team directly using the information on the trial page.

Sources: ClinicalTrials.gov
Last updated:

Trial data sourced from the ClinicalTrials.gov API. Location data reflects registered trial sites. This site does not provide medical advice.